Chirurgische Therapie im Stadium I und II des nichtkleinzelligen Lungenkarzinoms
Despite modern diagnostics and multimodal treatment strategies, overall survival of lung cancer could not be significantly improved in recent decades. The majority of patients with non-small cell lung cancer (NSCLC) have distant metastases at the time of diagnosis (57%) and only approximately 40% of...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
15. Oktober 2018
|
| In: |
Der Onkologe
Year: 2018, Jahrgang: 24, Heft: 12, Pages: 1009-1014 |
| ISSN: | 1433-0415 |
| DOI: | 10.1007/s00761-018-0471-3 |
| Online-Zugang: | Resolving-System, Volltext: https://doi.org/10.1007/s00761-018-0471-3 Verlag: https://link.springer.com/article/10.1007%2Fs00761-018-0471-3 
|
| Verfasserangaben: | Laura V. Klotz, Hauke Winter |
| Zusammenfassung: | Despite modern diagnostics and multimodal treatment strategies, overall survival of lung cancer could not be significantly improved in recent decades. The majority of patients with non-small cell lung cancer (NSCLC) have distant metastases at the time of diagnosis (57%) and only approximately 40% of patients are in a potentially curable tumor stage. |
|---|---|
| Beschreibung: | Gesehen am 18.11.2019 |
| Beschreibung: | Online Resource |
| ISSN: | 1433-0415 |
| DOI: | 10.1007/s00761-018-0471-3 |